Coherus Oncology, Inc.CHRSNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank31
3Y CAGR-21.9%
5Y CAGR-6.9%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
-21.9%/yr
vs +23.0%/yr prior
5Y CAGR
-6.9%/yr
Recent deceleration
Acceleration
-44.9pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $223.31M | -41.0% |
| 2024 | $378.63M | -17.8% |
| 2023 | $460.44M | -1.6% |
| 2022 | $467.92M | -20.7% |
| 2021 | $590.41M | +84.8% |
| 2020 | $319.50M | +28.7% |
| 2019 | $248.30M | +21.5% |
| 2018 | $204.42M | -12.5% |
| 2017 | $233.69M | -23.6% |
| 2016 | $306.04M | - |